货号:A285925 同义名:
LOXO-195;BAY 2731954
Selitrectinib是一种 TRK 激酶抑制剂 (TKI),对 TRKA 和 TRKC 的 IC50 值分别为 0.6 nM 和 <2.5 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50μL*10mM(DMSO) | ¥99随货¥69 | 咨询 | |
100μL*10mM(DMSO) | ¥139随货¥99 | 咨询 | |
250μL*10mM(DMSO) | ¥259随货¥189 | 咨询 | |
500μL*10mM(DMSO) | ¥369随货¥259 | 咨询 | |
10mM*1mL(DMSO) | ¥585 | 咨询 | |
1mg | ¥304 | 咨询 | |
5mg | ¥629 | 咨询 | |
10mg | ¥945 | 咨询 | |
25mg | ¥1827 | 咨询 | |
50mg | ¥2709 | 咨询 | |
100mg | ¥3528 | 咨询 |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | LOXO-195 is a new-generation and selective TRK inhibitor with IC50 values of 0.6nM, 2nM, 9.8nM, <2.5nM, 2.3nM and <2.5nM for TrkAWT, TrkAG595R, TrkAG667C, TrkCWT, TrkCG623R and TrkCG696A, respectively. Consistent with this, LOXO-195 displayed potent inhibitory effect on p-TRK in NIH-3T3 cells expressing TRK kinase acquired resistance mutations (IC50 1.6-64nM), with decrease p-ERK level (IC50 2-45nM) observed. Oral administration of LOXO-195 at dose of 30mg/kg, 100mg/kg and 300mg/kg, BID, led a dose-dependent tumor growth inhibition of mice xenograft these NIH-3T3 cells expressing different TRK resistance mutations. Distinguished from the other Trk inhibitor like larotrectinib, LOXO-195 abrogated resistance in TRK fusion–positive cancers that acquired kinase domain mutations, a shared liability with all existing TRK TKIs[1]. |
作用机制 | The specific structure of LOXO-195 with ability to accommodate the bulky, positively charged arginine side chain in the solvent front without any steric clashes distinguishes it from the other Trk inhibitor like larotrectinib.[1] |
Dose | Mice: 10 mg/kg[2] (p.o.), 30 mg/kg - 300 mg/kg[3] (p.o.) | ||||||||||||||
Administration | p.o. | ||||||||||||||
Pharmacokinetics |
|
计算器 | ||||
存储液制备 | ![]() | 1mg | 5mg | 10mg |
1 mM 5 mM 10 mM | 2.63mL 0.53mL 0.26mL | 13.14mL 2.63mL 1.31mL | 26.29mL 5.26mL 2.63mL |
CAS号 | 2097002-61-2 |
分子式 | C20H21FN6O |
分子量 | 380.419 |
别名 | LOXO-195;BAY 2731954 |
运输 | 蓝冰 |
存储条件 | In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,2-8°C |
溶解方案 | DMSO: 60 mg/mL(157.72 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |